New protocol: SubQ daratumumab + pomalidomide + dexamethasone for relapsed/refractory multiple myeloma
|New protocol: SubQ daratumumab + pomalidomide + dexamethasone for relapsed/refractory multiple myeloma|
Open-label phase 3 trial. Relapsed/refractory MM patients who received >=1 prior line of therapy
Presented at: 2021 ASH Annual Meeting; December 4, 2020. Abstract 412.
Reviewed by Ulas Darda Bayraktar, MD on Dec 7, 2020
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.